|
1L7I
Crystal Structure of the anti-ErbB2 Fab2C4
Deposited 2002-03-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
23–236(214 aa)
Fragment:light chain (residues 1-214)
|
Not recorded
|
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;292 K;35%-45% saturated (NH4)2SO4, 0.1 M Tris-HCl, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 1.80 Å
R-free 0.230
|
|
5VL7
PCSK9 complex with Fab33
Deposited 2017-04-25
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
127–236(110 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;292 K;potassium sodium phosphate
|
Resolution 3.50 Å
R-free 0.245
|
|
5VR9
CH1/Ckappa Fab based on Matuzumab
Deposited 2017-05-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
130–235(106 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;294 K;see publication for details
|
Resolution 2.15 Å
R-free 0.244
|
|
5VR9
CH1/Ckappa Fab based on Matuzumab
Deposited 2017-05-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
130–235(106 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;294 K;see publication for details
|
Resolution 2.15 Å
R-free 0.244
|
|
5VSI
CH1/Ckappa Fab mutant 15.1
Deposited 2017-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain L
130–235(106 aa)
|
Not recorded
|
SO4 SULFATE ION × 5
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;294 K;see publication
|
Resolution 1.51 Å
R-free 0.227
|
|
6BGT
Structure of Trastuzumab Fab mutant in complex with Her2 extracellular domain
Deposited 2017-10-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
127–236(110 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 6.5;293 K;100 mM MES, pH 6.5, 18% PEG3350, 10% glycerol
|
Resolution 2.70 Å
R-free 0.247
|
|
6MH2
Structure of Herceptin Fab without antigen
Deposited 2018-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
127–236(110 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;200 mM ammonium acetate, 100 mM Bis-Tris, pH 5.5, 25% v/v PEG3350
|
Resolution 2.80 Å
R-free 0.306
|
|
6MH2
Structure of Herceptin Fab without antigen
Deposited 2018-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
127–236(110 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;293 K;200 mM ammonium acetate, 100 mM Bis-Tris, pH 5.5, 25% v/v PEG3350
|
Resolution 2.80 Å
R-free 0.306
|
|
6MXR
Crystal structure of the dimeric bH1-Fab variant [HC-Y33W,HC-D98M,HC-G99M]
Deposited 2018-10-31
|
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
127–236(110 aa)
Chain L
127–236(110 aa)
|
Not recorded
|
CL CHLORIDE ION × 2
NA SODIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH;pH 5.6;295 K;0.1 M tris-sodium citrate, pH 5.6, 11% PEG4000, 8% isopropanol
|
Resolution 2.04 Å
R-free 0.200
|
|
6MY4
Crystal structure of the dimeric bH1-Fab variant [HC-Y33W,HC-D98M,HC-G99M,LC-S30bR]
Deposited 2018-11-01
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
127–236(110 aa)
Chain L
127–236(110 aa)
|
Mutation:S30bR,S30bR
Mutation:S30bR,S30bR
|
EDO 1,2-ETHANEDIOL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH;pH 8;295 K;0.05 M imidazole, pH 8.0, 18% PEG6000
|
Resolution 1.69 Å
R-free 0.230
|
|
6MY5
Crystal structure of the dimeric bH1-Fab variant [HC-Y33W,HC-D98F,HC-G99M,LC-S30bR]
Deposited 2018-11-01
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
127–236(110 aa)
Chain L
127–236(110 aa)
|
Mutation:S30bR,S30bR
Mutation:S30bR,S30bR
|
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH;pH 8;295 K;0.04 M imidazole, pH 8.0, 21% PEG6000
|
Resolution 1.73 Å
R-free 0.229
|
|
6U1N
GPCR-Beta arrestin structure in lipid bilayer
Deposited 2019-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
127–236(110 aa)
|
Not recorded
|
2CU 3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.00 Å
|
|
7ZLG
Cryo-EM structure of C-mannosyltransferase CeDPY19, in complex with acceptor peptide and bound to CMT2-Fab and anti-Fab nanobody
Deposited 2022-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain L
23–236(214 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 2.72 Å
|
|
7ZLI
Cryo-EM structure of C-mannosyltransferase CeDPY19, in complex with Dol25-P-Man and bound to CMT2-Fab and anti-Fab nanobody
Deposited 2022-04-15
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
23–236(214 aa)
|
Not recorded
|
IZY Dolichol monophosphate beta-D-Mannose × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 2.99 Å
|
|
7ZLJ
Cryo-EM structure of C-mannosyltransferase CeDPY19, in ternary complex with Dol25-P-C-Man and acceptor peptide, bound to CMT2-Fab and anti-Fab nanobody
Deposited 2022-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain L
23–236(214 aa)
|
Not recorded
|
IZU [(2~{R},3~{S},4~{S},5~{S},6~{R})-6-(hydroxymethyl)-3,4,5-tris(oxidanyl)oxan-2-yl]methyl-[(3~{S},6~{E},10~{Z},14~{E})-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenoxy]phosphinic acid × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 3.63 Å
|
|
9BDG
Influenza A virus Hemagglutinin H3/Darwin/6/2021 in complex with Fab ADI-85647
Deposited 2024-04-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain G
23–236(214 aa)
Chain H
23–236(214 aa)
Chain I
23–236(214 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 7
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.01 Å
|
|
9MY8
D7 Herpes Virus Simplex Neutralizing Nanobody Bound to HSV Glycoprotein gD
Deposited 2025-01-21
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain L
23–236(214 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.30 Å
|